UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 26, 2026
Sale
Calculated transaction value
$1.24M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 25, 2026
Public filing date
Aug 26, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$518.53
Aug 25, 2026
Close before public filing
$518.53
Aug 25, 2026
Return since public filing
-4.13%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,387 shares @ $518.8
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000128
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$6.2M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Aug 25, 2026 | $1.05M |
| United Therapeutics Corp UTHR | Sale | Aug 25, 2026 | $1.21M |
| United Therapeutics Corp UTHR | Sale | Aug 25, 2026 | $347.3K |
| United Therapeutics Corp UTHR | Sale | Aug 25, 2026 | $41.64K |
| United Therapeutics Corp UTHR | Exercise | Aug 25, 2026 | $0 |
| United Therapeutics Corp UTHR | Exercise | Aug 25, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 25, 2026 | $1.04M |
| United Therapeutics Corp UTHR Current | Sale | Aug 25, 2026 | $1.24M |